We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Assertio Holdings Inc | NASDAQ:ASRT | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.0549 | 6.99% | 0.84 | 0.30 | 1.24 | 0.84 | 0.7896 | 0.79 | 670,762 | 05:00:06 |
For more information about scheduling a one-on-one meeting with management, please contact your SVB Securities representative or Matt Kreps, Investor Relations for Assertio Holdings, at mkreps@darrowir.com.
About Assertio
Assertio Holdings, Inc. is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital, and pain and inflammation. Assertio has grown through business development including licensing, mergers, and acquisitions. For more information regarding Assertio Holdings, go to: https://www.assertiotx.com/.
Investor Contact:Matt KrepsManaging DirectorDarrow AssociatesAustin, TXM: 214-597-8200mkreps@darrowir.com
1 Year Assertio Chart |
1 Month Assertio Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions